慢性前列腺炎/慢性骨盆疼痛综合症

(重定向自类前列腺炎综合征

慢性非细菌性前列腺炎Chronic nonbacterial prostatitis)或慢性前列腺炎/慢性骨盆疼痛综合症chronic prostatitis/chronic pelvic pain syndrome )又称类前列腺炎综合征,是会导致男性盆腔疼痛英语Pelvic pain的一种疾病,是前列腺炎中找不到致病生物体类型的总称,涵盖找不到致病生物体的慢性前列腺炎各类型和前列腺痛;其特征是患者主述腰骶、会阴、外生殖器、尿道各种主观不适难忍,迁延难愈。没有明确的尿道感染病史。部分类前列腺炎综合征患者尿流率图曲线见齿型波,最大尿流率正常;平均尿流率时间相对延长。

慢性非细菌性前列腺炎
(Chronic nonbacterial prostatitis)
类型urologic chronic pelvic pain syndrome[*]慢性前列腺炎
分类和外部资源
医学专科泌尿外科
ICD-10N41
DiseasesDB10801
MedlinePlus000524
eMedicine437745
[编辑此条目的维基数据]

此病应与其他类型的前列腺炎区分,如慢性细菌性前列腺炎急性细菌性前列腺炎[1][2]。此外,这种疾病以前被称为前列腺疼痛(prostatodynia)。

症状

编辑

慢性前列腺炎/慢性骨盆疼痛综合征的主要特征是骨盆或会阴疼痛,且没有尿路感染的迹象[3],并持续超过3个月[4]——此乃关键症状。它的症状可能会时好时坏。痛楚的程度可以从轻微的,以至使人虚弱。痛楚可散发至背部和直肠,令人坐下时感到不舒服。可于会阴、睾丸、阴茎前端、耻骨或膀胱这些区域上感到痛楚[5]排尿困难关节痛肌肉痛、不明原因的乏力、腹痛、阴茎灼痛也是时常会出现的症状。尿频和尿急可能是暗示患者患的是间质性膀胱炎(发炎的是膀胱,而不是前列腺)。由神经和肌肉介导的射精后疼痛,仍是其一大特点[6],此特点可用以把慢性前列腺炎/慢性骨盆疼痛综合症患者与良性前列腺增生症区分。有些患者报告说自己性欲低下、性功能障碍和勃起困难。

原因

编辑

神经、压力和荷尔蒙

编辑

慢性前列腺炎/慢性骨盆疼痛综合症是免疫、神经和内分泌系统与心理因素之间的相互作用导致[7]。该病背后的理论包括压力令下丘脑-垂体-肾上腺轴功能失调,和肾上腺皮质激素(内分泌)异常[8][9],以及出现神经源性炎症英语Neurogenic inflammation[10][11][12]、肌筋膜疼痛症候群[13][14]。在后两类,是由于过去的创伤、感染或焦虑性格导致局部神经系统的失调,慢性无意识地绷紧骨盆(受神经细胞释放物质(如物质P英语Substance P)的调节)亦会导致炎症。前列腺(和泌尿生殖道其它部分:膀胱、尿道、睾丸)亦能因长期活化在骨盆神经端部的肥大细胞而发炎。类似压力诱发的生殖泌尿炎症已经在其他哺乳动物实验中发现[15]。然而,前列腺炎组织学检查与国立卫生研究院的慢性前列腺炎症状指数之间没有关联[16]

细菌感染学说曾在这一领域长时间占居主导地位,但于2003年在华盛顿大学由李博士(Dr Lee)和理查德·伯杰(Richard Berger)教授带领的研究显示细菌感染并不重要。该研究发现,三分之一正常男性或患者前列腺都有类近的细菌数量[17]。这一观点得到了西北大学泌尿外科主任和教授安东尼·谢弗博士(Dr Anthony Schaeffer)赞同,在2003年的泌尿外科杂志中,他指出“这些数据表明,细菌在慢性骨盆疼痛综合症的病情发展中并不扮演一个显著角色[18] 。”;并在一年后与他的同事发表他的研究,显示抗生素对慢性前列腺炎/慢性骨盆疼痛综合症基本上是无用的[19][20]。由于这些研究报告的发表,UCPPS的病因研究重点已经从感染转移到神经肌肉、行为、心理和遗传这些方面去研究(UCPPS:慢性前列腺炎/慢性骨盆疼痛综合症、间质性膀胱炎/膀胱疼痛综合症),其中强调下尿路和其他生理系统之间的相互作用[21]。现在的研究把UCPPS视为一种全身性疾病[21]。为佐证这项提议,2005年的研究表明,压力是与第三类前列腺炎慢性前列腺炎/慢性骨盆疼痛综合症)相关的[22]

与间质性膀胱炎/膀胱疼痛综合症重叠

编辑

一些研究人员认为,慢性骨盆疼痛综合症是间质性膀胱炎/膀胱疼痛综合症的一种形式。2007年,美国国立糖尿病消化与肾病研究所英语National Institute of Diabetes and Digestive and Kidney Diseases开始把间质性膀胱炎/膀胱疼痛综合症和慢性前列腺炎/慢性骨盆疼痛综合症组合,统称泌尿系统慢性盆腔疼痛综合症(Urologic Chronic Pelvic Pain Syndromes )。对间质性膀胱炎/膀胱疼痛综合症有效的治疗,如槲皮素[23],在慢性前列腺炎/慢性骨盆疼痛综合症中同样有一些疗效[24]。最近的研究集中在基因组学蛋白质组学方面的相关条件[25]

患者可能在膀胱充盈时出现疼痛,这也是膀胱疼痛综合症的典型症状[26]

气候

编辑

环境温度在病情上也扮演一个角色。患者很多时候会报告说寒冷引起症状加重,热力则很多时候会被报告说改善症状[27]。这则显得寒冷是可以引发导致慢性前列腺炎/慢性骨盆疼痛综合症的过程的因素之一[28]。寒冷也会导致症状加重和复发[28][29]。一项调查表明,居住在寒冷气候下的芬兰北部的男性前列腺炎症状的发生率比在世界其它地方报告的数字高[30]

食物过敏

编辑

有证据表明,食物过敏和不耐受可能在慢性前列腺炎/慢性骨盆疼痛综合症方面起了加重病情的作用,也许是肥大细胞的介导机制所致。也有一些证据表明在一些患者的泌尿系统慢性盆腔疼痛综合症(如间质性膀胱炎/膀胱疼痛综合症和慢性前列腺炎/慢性骨盆疼痛综合症)与麸质不耐英语Non-celiac_gluten_sensitivity有关[31][32][33]。因此,患者通过识别问题食品然后把其从饮食中消除可能对减轻症状有帮助。但这方面的研究较为缺乏。

诊断

编辑

没有确切的对慢性前列腺炎/慢性骨盆疼痛综合症的诊断测试。这是一种所知甚少的病症。尽管它占所有前列腺炎诊断的90%-95%[34]。它可在任何年龄的男性中被发现,35-45岁为男性发病的高峰[35]。慢性前列腺炎/慢性骨盆疼痛综合症可以根据前列腺液分泌物中的脓细胞水平,分为炎症(分类ⅢA)或是非炎症(分类ⅢB),但这些子类别在临床上用途有限。在分类为炎症的情况下,尿液、精液、其它从前列腺流出来的液体包含脓细胞(死去的白血细胞或白细胞);而分类为非炎症的情况下,并无发现脓细胞存在。最近的研究质疑分类Ⅲa和Ⅲb之间的区别,因为如果脓细胞和更细微的迹象(如所测量的细胞因子)被忽略,这两类都表明是炎症[36]

2006年,中国的研究人员发现,患有Ⅲa和Ⅲb型的男性在其前列腺按摩液(EPS)均具有抗炎细胞因子TGFβ1英语TGFβ1和促炎细胞因子干扰素伽玛的显著升高迹象(与对照组相比)。因此,这些细胞因子的测量可用于诊断第Ⅲ型前列腺炎[37]。2010年的研究发现,神经生长因子英语Nerve growth factor也可以用作作为一种生物标志物来测量[38]

对于慢性前列腺炎/慢性骨盆疼痛综合症患者,尿液分析并以此表示前列腺分泌物中白细胞是有争议的,因为确定炎性和非炎性之间的差异是没有任何作用[39]。血清PSA测试、前列腺常规影像、沙眼衣原体和脲测试对患者并不能提供任何好处[39]

>50%慢性骨盆疼痛综合症患者存在前列腺外腹部/骨盆压痛,但只有7%的痛楚受到控制[40]。健康男性在其精液发现的细菌比患有慢性骨盆疼痛综合症的男性略多[41]。在无症状的对照人群中,白细胞和细菌培养阳性的高发病率引起了人们对临床应用4-glass test作为慢性前列腺炎/慢性骨盆疼痛综合症诊断工具的疑惑[41]。美国泌尿外科医生使用4-glass test目前是十分罕见,经常使用它的只有4%[42]

患上慢性前列腺炎/慢性骨盆疼痛综合症的男性一般人更容易患上慢性疲劳综合症[43]大肠激躁症

有些实验测试可能在未来有用的,包括测量精液和前列腺液的细胞因子水平的测试。各种研究已表明在慢性前列腺炎/慢性骨盆疼痛综合症中,炎症标记物会增加,如细胞因子[44]、髓过氧化物酶[45]、趋化因子[46][47]的水平升高。

鉴别诊断

编辑

有些状态也有与慢性前列腺炎类似的症状,膀胱颈部肥大和尿道狭窄可能由于尿液返流引起相似的症状,可以通过膀胱镜和尿动力学测试排除[48][49][50]

命名法

编辑

慢性前列腺炎/慢性骨盆疼痛综合症有时会区分做IIIa型(炎症)和IIIb型(非炎症)[51],取决于脓胞(白细胞)是否可以在患者的前列腺液分泌物(EPS)中找到。一些研究者质疑这种分类的有效性并呼吁抛弃four-glass test[52]

2007年,美国国立糖尿病消化与肾病研究所英语National Institute of Diabetes and Digestive and Kidney Diseases以研究为目的,开始使用“泌尿系统慢性盆腔疼痛综合症”此一伞式术语,指与膀胱(即间质性膀胱炎/膀胱疼痛综合症)和前列腺(即慢性前列腺炎/慢性骨盆疼痛综合症)有关的疼痛综合症[53]

此疾病的旧版术语是前列腺痛和非细菌性前列腺炎。

治疗

编辑

慢性骨盆疼痛综合症是很难治疗的[54]

心理治疗和物理治疗

编辑

第三类前列腺炎可能除了焦虑情绪外,并没有任何的触发因素。且患者经常伴有强迫症恐慌症或其他焦虑光谱的问题[55][56][57]。这理论上会令骨盆区域出现敏化状态,令肌肉循环性地紧张,并提高神经反馈。目前的治疗方案在很大程度上集中于使紧张的盆腔或肛门部位(通常被称为激痛点)放松,方法包括直肠按摩、对该区域进行物理治疗和放松疗法,以减少致病的压力。


有氧运动可以帮助那些没患上慢性疲劳综合症或不会由运动加剧痛苦症状的慢性前列腺炎/慢性骨盆疼痛综合症患者[58]。据报告,针灸也对一些患者有帮助[59]。慢性非细菌性前列腺炎(第III类),也被称为慢性前列腺炎/慢性骨盆疼痛综合症,这使得大多数男性被诊断为“前列腺炎”。一最近已经公布了个称为“斯坦福大学治疗方案英语Wise–Anderson Protocol[13][14][60]的治疗方案,其包括:

  • 药物治疗(使用三环类抗抑郁药苯二氮卓
  • 心理治疗(矛盾放松(paradoxical relaxation)训练,专门针对盆腔疼痛,早在20世纪期间由埃德蒙·雅各布森发展的一种渐进式放松技术)
  • 物理疗法(盆底和腹部肌肉的激痛点释放疗法,而且进行瑜伽式的练习,以放松盆底和腹部肌肉为目的)[13][14]

生物反馈理疗对学习如何控制盆底肌肉可能是有帮助的[61][62][63][64]。生物反馈对青春期的慢性前列腺炎治疗是良好的疗法(主要是治疗排尿问题)[65]

药理治疗

编辑

许多药物可用于治疗这种疾病。α-受体阻滞剂英语Alpha blocker或抗生素似乎是最有效的。非甾体抗炎药如布洛芬,提供的益处则较少[66]

  • 抗生素治疗是有争议的。有些抗生素已发现对病情有好处[66];但有些人质疑抗生素的效用[67]。抗生素已知具有抗炎特性,因此这被认为说明了它们的部分功效并建议用于治疗慢性骨盆疼痛综合症[18]。抗生素如喹诺酮类,四环素类和大环内酯类缺乏没有感染的直接抗炎性质。阻断细胞因子如白细胞介素1族白细胞介素-8肿瘤坏死因子,都在男性慢性前列腺炎患者的精液和列腺按摩液中发现升高的现象[68]
  • α-受体阻滞剂(坦索罗辛阿夫唑嗪)对慢性骨盆疼痛综合症的有效性备受质疑,2006年的一项荟萃分析发现,他们在持续至少3个月的治疗中度有益[69]
  • 雌激素再吸收抑制剂,例如美帕曲星英语Mepartricin,能改善排尿、减少神经疼痛,提高慢性非细菌性前列腺炎患者的生活质量[70]
  • 还没有在临床试验中经妥善评价,但有轶事证据支持的药物包括:加巴喷丁苯二氮䓬类阿米替林[71]

外科手术

编辑

经尿道针切除前列腺英语Transurethral needle ablation of the prostate已在实验被证明无效[72]

流行病学

编辑

慢性骨盆疼痛综合症的每年人口患病率为0.5%[73]。38%初级卫生保健提供者表示他们从来没有见过慢性前列腺炎/慢性骨盆疼痛综合症患者[74]。然而,暗示慢性前列腺炎/慢性骨盆疼痛综合症的总患病率为6.3%[75]

预后

编辑

近年来,慢性前列腺炎/慢性骨盆疼痛综合症的预后出现改善,归因于多峰治疗、植物疗法,旨在通过激痛点释放和控制焦虑,使骨盆神经平静下来,还有治疗慢性疼痛[76][77][78]

著名病例

编辑

参考资料

编辑
  1. ^ Schaeffer, A. J.; Datta, N. S.; Fowler Jr, J. E.; Krieger, J. N.; Litwin, M. S.; Nadler, R. B.; Nickel, J. C.; Pontari, M. A.; Shoskes, D. A.; Zeitlin, S. I.; Hart, C.; Chronic Prostatitis Collaborative Research Network. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology. 2002, 60 (6 Suppl): 1–4. PMID 12521576. doi:10.1016/S0090-4295(02)01979-9. 
  2. ^ Holt JD1 et al. Common Questions About Chronic Prostatitis. Am Fam Physician. 2016 Feb 15;93(4):290-6. PMID 26926816
  3. ^ Schaeffer AJ. Epidemiology and evaluation of chronic pelvic pain syndrome in men. Int J Antimicrob Agents. 2007, 31: S108–11. PMID 18164597. doi:10.1016/j.ijantimicag.2007.08.027. 
  4. ^ Luzzi GA. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management. Journal of the European Academy of Dermatology and Venereology : JEADV. 2002, 16 (3): 253–6. PMID 12195565. doi:10.1046/j.1468-3083.2002.00481.x. 
  5. ^ Clemens, J Quentin; Meenan, Richard T; O'Keeffe Rosetti, Maureen C; Gao, Sara Y; Calhoun, Elizabeth A. Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community. J Urol. Dec 2005, 174 (6): 2319–22. PMID 16280832. doi:10.1097/01.ju.0000182152.28519.e7. 
  6. ^ Shoskes DA, Landis JR, Wang Y, Nickel JC, Zeitlin SI, Nadler R; Landis; Wang; Nickel; Zeitlin; Nadler; Chronic Prostatitis Collaborative Research Network Study Group. Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J. Urol. August 2004, 172 (2): 542–7. PMID 15247725. doi:10.1097/01.ju.0000132798.48067.23. 
  7. ^ Pontari MA, Ruggieri MR; Ruggieri. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. May 2008, 179 (5 Suppl): S61–7. PMID 18405756. doi:10.1016/j.juro.2008.03.139. 
  8. ^ Anderson RU, Orenberg EK, Chan CA, Morey A, Flores V; Orenberg; Chan; Morey; Flores. Psychometric Profiles and Hypothalamic-Pituitary-Adrenal Axis Function in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Urol. 2008, 179 (3): 956–60. PMC 2694575 . PMID 18207189. doi:10.1016/j.juro.2007.10.084. 
  9. ^ Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CA, Nickel JC; Joffe; Soldin; Bolus; Buffington; Nickel. Adrenocortical Hormone Abnormalities in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Urology. 2008, 71 (2): 261–266. PMC 2390769 . PMID 18308097. doi:10.1016/j.urology.2007.09.025. 
  10. ^ Theoharides TC, Cochrane DE; Cochrane. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 2004, 146 (1–2): 1–12. PMID 14698841. doi:10.1016/j.jneuroim.2003.10.041. 
  11. ^ Theoharides TC, Kalogeromitros D; Kalogeromitros. The critical role of mast cells in allergy and inflammation. Ann. N. Y. Acad. Sci. 2006, 1088: 78–99. Bibcode:2006NYASA1088...78T. PMID 17192558. doi:10.1196/annals.1366.025. 
  12. ^ Sant GR, Kempuraj D, Marchand JE, Theoharides TC; Kempuraj; Marchand; Theoharides. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007, 69 (4 Suppl): 34–40. PMID 17462477. doi:10.1016/j.urology.2006.08.1109. 
  13. ^ 13.0 13.1 13.2 Anderson RU, Wise D, Sawyer T, Chan C; Wise; Sawyer; Chan. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J. Urol. 2005, 174 (1): 155–60. PMID 15947608. doi:10.1097/01.ju.0000161609.31185.d5. 
  14. ^ 14.0 14.1 14.2 Anderson RU, Wise D, Sawyer T, Chan CA; Wise; Sawyer; Chan. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J. Urol. 2006, 176 (4 Pt 1): 1534–8; discussion 1538–9. PMID 16952676. doi:10.1016/j.juro.2006.06.010. 
  15. ^ Alexacos N, Pang X, Boucher W, Cochrane DE, Sant GR, Theoharides TC; Pang; Boucher; Cochrane; Sant; Theoharides. Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress. Urology. 1999, 53 (5): 1035–40. PMID 10223502. doi:10.1016/S0090-4295(98)00627-X. 
  16. ^ Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS; Roehrborn; O'Leary; Bostwick; Somerville; Rittmaster. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J. Urol. 2007, 178 (3 Pt 1): 896–900; discussion 900–1. PMID 17632164. doi:10.1016/j.juro.2007.05.041. 
  17. ^ Lee JC; Muller CH; Rothman I; et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J. Urol. February 2003, 169 (2): 584–7; discussion 587–8. PMID 12544312. doi:10.1097/01.ju.0000045673.02542.7a (不活跃 2015-01-11). 
  18. ^ 18.0 18.1 Schaeffer AJ. Editorial: Emerging concepts in the management of prostatitis/chronic pelvic pain syndrome. J Urol. 2003, 169 (2): 597–598. PMID 12544315. doi:10.1016/S0022-5347(05)63961-4. 
  19. ^ Alexander RB; Propert KJ; Schaeffer AJ; et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med. 2004, 141 (8): 581–9. PMID 15492337. doi:10.7326/0003-4819-141-8-200410190-00005. 
  20. ^ Nickel JC; Downey J; Clark J; et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003, 62 (4): 614–7. PMID 14550427. doi:10.1016/S0090-4295(03)00583-1. 
  21. ^ 21.0 21.1 Multi-disciplinary Approach to the Study of Chronic Pelvic Pain. NIDDK—Department of Health and Human Services. 2007 [2008-02-12]. (原始内容存档于2018-07-15). 
  22. ^ Ullrich PM, Turner JA, Ciol M, Berger R; Turner; Ciol; Berger. Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Annals of Behavioral Medicine. 2005, 30 (2): 112–8. PMID 16173907. doi:10.1207/s15324796abm3002_3. 
  23. ^ Theoharides, TC.; Whitmore, K.; Stanford, E.; Moldwin, R.; O'Leary, MP. Interstitial cystitis: bladder pain and beyond. Expert Opin Pharmacother. Dec 2008, 9 (17): 2979–94. PMID 19006474. doi:10.1517/14656560802519845. 
  24. ^ Murphy, AB.; Macejko, A.; Taylor, A.; Nadler, RB. Chronic prostatitis: management strategies. Drugs. 2009, 69 (1): 71–84. PMID 19192937. doi:10.2165/00003495-200969010-00005. 
  25. ^ Dimitrakov, J.; Dimitrakova, E. Urologic chronic pelvic pain syndrome—looking back and looking forward. Folia Med (Plovdiv). 2009, 51 (3): 42–4. PMID 19957562. 
  26. ^ Rourke W, Khan SA, Ahmed K, Masood S, Dasgupta P, Khan MS; Khan; Ahmed; Masood; Dasgupta; Khan. Painful bladder syndrome/interstitial cystitis: aetiology, evaluation and management. Arch Ital Urol Androl. June 2014, 86 (2): 126–31. PMID 25017594. doi:10.4081/aiua.2014.2.126. 
  27. ^ Hedelin H, Jonsson K; Jonsson. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time. Scand. J. Urol. Nephrol. 2007, 41 (6): 516–20. PMID 17853027. doi:10.1080/00365590701428517. 
  28. ^ 28.0 28.1 Hedelin H, Jonsson K; Jonsson. Chronic abacterial prostatitis and cold exposure: an explorative study. Scand. J. Urol. Nephrol. 2007, 41 (5): 430–5. PMID 17853032. doi:10.1080/00365590701365123. 
  29. ^ Gao DJ, Guo YS, Yu HY, Wang YJ, Cui WG; Guo; Yu; Wang; Cui. [Prevalence and related factors of prostatitis-like symptoms in young men]. Zhonghua Nan Ke Xue. December 2007, 13 (12): 1087–90. PMID 18284056 (中文). 
  30. ^ Mehik A, Hellström P, Lukkarinen O, Sarpola A, Järvelin M; Hellström; Lukkarinen; Sarpola; Järvelin. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int. September 2000, 86 (4): 443–8. PMID 10971269. doi:10.1046/j.1464-410X.2000.00836.x. 
  31. ^ Catassi C. Gluten Sensitivity. Ann Nutr Metab (Review). 2015,. 67 Suppl 2: 16–26 [2016-08-01]. PMID 26605537. doi:10.1159/000440990. (原始内容存档于2016-03-16). 
  32. ^ Rostami K, Hogg-Kollars S. A Patient's Journey. Non-coeliac gluten sensitivity. BMJ. 2012, 345: e7982. PMID 23204003. 
  33. ^ Gluten and CP/CPPS. Prostatitis Network. [2016-03-16]. (原始内容存档于2016-03-27). 
  34. ^ Habermacher GM, Chason JT, Schaeffer AJ; Chason; Schaeffer. Prostatitis/chronic pelvic pain syndrome. Annu. Rev. Med. 2006, 57: 195–206. PMID 16409145. doi:10.1146/annurev.med.57.011205.135654. 
  35. ^ Daniel Shoskes. Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Humana Press. 2008: 171. ISBN 1-934115-27-4. 
  36. ^ A Pontari, M. Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology. Dec 2002, 60 (6 Suppl): 29–33; discussion 33–4. PMID 12521589. doi:10.1016/S0090-4295(02)02381-6. 
  37. ^ Ding XG, Li SW, Zheng XM, Hu LQ; Li; Zheng; Hu. [IFN-gamma and TGF-beta1, levels in the EPS of patients with chronic abacterial prostatitis]. Zhonghua Nan Ke Xue. 2006, 12 (11): 982–4. PMID 17146921 (中文). 
  38. ^ Watanabe, T.; Inoue, M.; Sasaki, K.; Araki, M.; Uehara, S.; Monden, K.; Saika, T.; Nasu, Y.; Kumon, H.; Chancellor, Michael B. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int. Sep 2010, 108 (2): 248–51. PMID 20883485. doi:10.1111/j.1464-410X.2010.09716.x. 
  39. ^ 39.0 39.1 Weidner W, Anderson RU; Anderson. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents. 2007, 31 (2): S91–5. PMID 18162376. doi:10.1016/j.ijantimicag.2007.07.044. 
  40. ^ Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S; Berger; Elmi; Landis; Propert; Zeitlin; Chronic Prostatitis Collaborative Research Network Study Group. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J. Urol. 2008, 179 (2): 556–60. PMC 2664648 . PMID 18082223. doi:10.1016/j.juro.2007.09.088. 
  41. ^ 41.0 41.1 Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ; Alexander; Schaeffer; Landis; Knauss; Propert; Chronic Prostatitis Collaborative Research Network Study Group. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J. Urol. 2003, 170 (3): 818–22. PMID 12913707. doi:10.1097/01.ju.0000082252.49374.e9. 
  42. ^ McNaughton Collins, M.; Fowler, FJ.; Elliott, DB.; Albertsen, PC.; Barry, MJ. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test?. Urology. Mar 2000, 55 (3): 403–7. PMID 10699621. doi:10.1016/S0090-4295(99)00536-1. 
  43. ^ Leslie A Aaron; et al. Comorbid Clinical Conditions in Chronic Fatigue: A Co-Twin Control Study. J Gen Intern Med. 2001, 16 (1): 24–31. PMC 1495162 . PMID 11251747. doi:10.1111/j.1525-1497.2001.03419.x. 
  44. ^ He, L.; Wang, Y.; Long, Z.; Jiang, C. Clinical Significance of IL-2, IL-10, and TNF-alpha in Prostatic Secretion of Patients With Chronic Prostatitis. Urology. Dec 2009, 75 (3): 654–7. PMID 19963254. doi:10.1016/j.urology.2009.09.061. 
  45. ^ Pasqualotto, FF.; Sharma, RK.; Potts, JM.; Nelson, DR.; Thomas, AJ.; Agarwal, A. Seminal oxidative stress in patients with chronic prostatitis. Urology. Jun 2000, 55 (6): 881–5. PMID 10840100. doi:10.1016/S0090-4295(99)00613-5. 
  46. ^ Penna, G.; Mondaini, N.; Amuchastegui, S.; Degli Innocenti, S.; Carini, M.; Giubilei, G.; Fibbi, B.; Colli, E.; et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol. Feb 2007, 51 (2): 524–33; discussion 533. PMID 16905241. doi:10.1016/j.eururo.2006.07.016. 
  47. ^ Khadra, A.; Fletcher, P.; Luzzi, G.; Shattock, R.; Hay, P. Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int. May 2006, 97 (5): 1043–6. PMID 16643489. doi:10.1111/j.1464-410X.2006.06133.x. 
  48. ^ Chiari R. Urethral obstruction and prostatitis. Int Urol Nephrol. 1983, 15 (3): 245–55. PMID 6654631. doi:10.1007/BF02083011. 
  49. ^ Hruz P, Danuser H, Studer UE, Hochreiter WW; Danuser; Studer; Hochreiter. Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy. Eur. Urol. 2003, 44 (1): 106–10; discussion 110. PMID 12814683. doi:10.1016/S0302-2838(03)00203-3. 
  50. ^ Romero Pérez P, Mira Llinares A; Mira Llinares. [Complications of the lower urinary tract secondary to urethral stenosis]. Actas Urol Esp. 1996, 20 (9): 786–93. PMID 9065088 (西班牙语). 
  51. ^ Prostatitis: Benign Prostate Disease: Merck Manual Professional. [2010-04-17]. (原始内容存档于2010-04-28). 
  52. ^ Treatment of Chronic Prostatitis. www.medscape.com. [2010-04-18]. (原始内容存档于2017-04-27). 
  53. ^ Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. NIDDK. 2007 [2008-01-11]. (原始内容存档于2018-07-15). 
  54. ^ Potts J, Payne RE; Payne. Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleveland Clinic journal of medicine. May 2007, 74 (Suppl 3): S63–71. PMID 17549825. doi:10.3949/ccjm.74.Suppl_3.S63. 
  55. ^ Anderson, RU.; Orenberg, EK.; Morey, A.; Chavez, N.; Chan, CA. Stress induced hypothalamus-pituitary-adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. Nov 2009, 182 (5): 2319–24. PMID 19762053. doi:10.1016/j.juro.2009.07.042. 
  56. ^ Li, HC.; Wang, ZL.; Li, HL.; Zhang, N.; Chen, HW.; Zhang, P.; Gan, WM.; Chong, T.; Wang, ZM. [Correlation of the prognosis of chronic prostatitis/chronic pelvic pain syndrome with psychological and other factors: a Cox regression analysis]. Zhonghua Nan Ke Xue. Aug 2008, 14 (8): 723–7. PMID 18817346. 
  57. ^ Clemens, JQ.; Brown, SO.; Calhoun, EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol. Oct 2008, 180 (4): 1378–82. PMC 2569829 . PMID 18707716. doi:10.1016/j.juro.2008.06.032. 
  58. ^ Giubilei G; Mondaini N; Minervini A; et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments—could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study. J. Urol. 2007, 177 (1): 159–65. PMID 17162029. doi:10.1016/j.juro.2006.08.107. 
  59. ^ Rosted P. Chronic prostatitis/chronic pelvic pain syndrome and acupuncture—a case report. Acupunct Med. 2007, 25 (4): 198–9. PMID 18160930. doi:10.1136/aim.25.4.198. 
  60. ^ The Stanford Protocol. 2005 [2006-12-09]. (原始内容存档于2021-03-07). 
  61. ^ Cornel EB, van Haarst EP, Schaarsberg RW, Geels J; Van Haarst; Schaarsberg; Geels. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur. Urol. 2005, 47 (5): 607–11. PMID 15826751. doi:10.1016/j.eururo.2004.12.014. 
  62. ^ Clemens, J. Q.; Nadler, R. B.; Schaeffer, A. J.; Belani, J.; Albaugh, J.; Bushman, W. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 2000, 56 (6): 951–955. PMID 11113739. doi:10.1016/S0090-4295(00)00796-2. 
  63. ^ Kaplan, S. A.; Santarosa, R. P.; D'alisera, P. M.; Fay, B. J.; Ikeguchi, E. F.; Hendricks, J.; Klein, L.; Te, A. E. Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. The Journal of Urology. 1997, 157 (6): 2234–2237. PMID 9146624. doi:10.1016/S0022-5347(01)64727-X. 
  64. ^ He, W.; Chen, M.; Zu, X.; Li, Y.; Ning, K.; Qi, L. Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment. BJU international. 2009, 105 (7): 975–977. PMID 19751259. doi:10.1111/j.1464-410X.2009.08850.x. 
  65. ^ Li, Y.; Qi, L.; Wen, J.; Zu, X.; Chen, Z. Chronic prostatitis during puberty. BJU international. 2006, 98 (4): 818–821. PMID 16978277. doi:10.1111/j.1464-410X.2006.06386.x. 
  66. ^ 66.0 66.1 Anothaisintawee, T; Attia, J; Nickel, JC; Thammakraisorn, S; Numthavaj, P; McEvoy, M; Thakkinstian, A. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.. JAMA: The Journal of the American Medical Association. Jan 5, 2011, 305 (1): 78–86. PMID 21205969. doi:10.1001/jama.2010.1913. 
  67. ^ Wagenlehner, FM.; Naber, KG.; Bschleipfer, T.; Brähler, E.; Weidner, W. Prostatitis and male pelvic pain syndrome: diagnosis and treatment. Dtsch Arztebl Int. Mar 2009, 106 (11): 175–83. PMC 2695374 . PMID 19568373. doi:10.3238/arztebl.2009.0175 (不活跃 2015-01-11). 
  68. ^ Shoskes DA. Use of antibiotics in chronic prostatitis syndromes. Can J Urol. June 2001,. 8 Suppl 1: 24–8. PMID 11442994. 
  69. ^ Yang G, Wei Q, Li H, Yang Y, Zhang S, Dong Q; Wei; Li; Yang; Zhang; Dong. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials. J. Androl. 2006, 27 (6): 847–52. PMID 16870951. doi:10.2164/jandrol.106.000661. ...treatment duration should be long enough (more than 3 months) 
  70. ^ Cohen JM, Fagin AP, Hariton E, Niska JR, Pierce MW, Kuriyama A, Whelan JS, Jackson JL, Dimitrakoff JD. Therapeutic Intervention for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/ CPPS): A Systematic Review and Meta-Analysis. PLOS ONE. 2012, 7 (8): e41941. Bibcode:2012PLoSO...741941C. PMID 22870266. doi:10.1371/journal.pone.0041941. 
  71. ^ Curtis Nickel, J; Baranowski, AP; Pontari, M; Berger, RE; Tripp, DA. Management of Men Diagnosed With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Who Have Failed Traditional Management. Reviews in urology. 2007, 9 (2): 63–72. PMC 1892625 . PMID 17592539. 
  72. ^ Leskinen, MJ.; Kilponen, A.; Lukkarinen, O.; Tammela, TL. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology. Aug 2002, 60 (2): 300–4. PMID 12137830. doi:10.1016/S0090-4295(02)01704-1. 
  73. ^ Taylor BC; Noorbaloochi S; McNaughton-Collins M; et al. Excessive antibiotic use in men with prostatitis. Am. J. Med. May 2008, 121 (5): 444–9. PMC 2409146 . PMID 18456041. doi:10.1016/j.amjmed.2008.01.043. 
  74. ^ Phillp Hannno. Defining The Urologic Chronic Pelvic Pain Syndromes: A New Beginning—An International Symposium. Urotoday. [2008-07-22]. (原始内容存档于2015-02-22). 
  75. ^ Daniels NA, Link CL, Barry MJ, McKinlay JB; Link; Barry; McKinlay. Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome. J Natl Med Assoc. May 2007, 99 (5): 509–16. PMC 2576075 . PMID 17534008. 
  76. ^ Duclos, AJ.; Lee, CT.; Shoskes, DA. Current treatment options in the management of chronic prostatitis. Ther Clin Risk Manag. Aug 2007, 3 (4): 507–12. PMC 2374945 . PMID 18472971. 
  77. ^ Shoskes, DA.; Katz, E. Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep. Jul 2005, 6 (4): 296–9. PMID 15978233. doi:10.1007/s11934-005-027-0 (不活跃 2015-01-11). 
  78. ^ Bergman, J.; Zeitlin, SI. Prostatitis and chronic prostatitis/chronic pelvic pain syndrome. Expert Rev Neurother. Mar 2007, 7 (3): 301–7. PMID 17341178. doi:10.1586/14737175.7.3.301. 
  79. ^ Anderson goes. Australian Broadcasting Corporation Transcript. [2008-05-12]. (原始内容存档于2016-10-28). 
  80. ^ The Intimate Sex Lives of Famous People. Doubleday. 2008 [2010-12-21]. ISBN 9781932595291. 
  81. ^ Allison Reitz. John Cleese tour pays the 'Alimony' with West Coast comedy shows. tickenews.com. July 2009 [2009-07-28]. (原始内容存档于2009-07-28). The star of Monty Python and "A Fish Called Wanda" has been diagnosed with prostatitis, the inflammation of the prostate gland and is undergoing treatment. 
  82. ^ Roger Ebert. The whole truth from Vincent Gallour Flies. Chicago Sun Times. [2008-05-30]. (原始内容存档于2008-05-13). 
  83. ^ Glenn Gould as Patient. [2008-05-12]. (原始内容存档于2008-06-07). 
  84. ^ Dallek, Robert. An Unfinished Life: John F. Kennedy 1917-1963. Boston: Little, Brown. 2003: 123 [2016-08-02]. ISBN 0-316-17238-3. (原始内容存档于2010-03-26). 
  85. ^ The Howard Stern Show for September 4, 2007. Howard Stern. [2008-05-12]. (原始内容存档于2013-03-21). 
  86. ^ The Howard Stern Show for September 5, 2007, PULLING OUT A PLUM. Howard Stern. [2008-05-12]. (原始内容存档于2013-03-21). 
  87. ^ Leavitt, David. Styron’s Choices. NY Times. 2008-05-11 [2008-05-12]. (原始内容存档于2018-11-18). 

外部链接

编辑